WNT brown cluster
|
(342 probes)
|
Wnt/β-catenin Signaling |
0.002 |
FZD10, CDH2, WIF1, DKK4, WNT16, DKK2, LEF1, DKK1, FZD7
|
|
|
Glioblastoma Multiforme Signaling |
0.003 |
FZD10, PDGFRA, CDK6, WNT16, PLCB1, LEF1, PDGFC, FZD7
|
|
|
Basal Cell Carcinoma Signaling |
0.006 |
FZD10, BMP4, WNT16, LEF1, FZD7
|
|
|
Ovarian Cancer Signaling |
0.006 |
FZD10, LHCGR, WNT16, LEF1, MMP2, PDGFC, FZD7
|
SHH cluster family B)
|
(358 probes)
|
Hepatic Fibrosis |
0.002 |
COL1A2, COL1A1, IGFBP4, FGFR1, IGFBP5, PGF, COL3A1, EGFR
|
|
|
Molecular Mechanisms of Cancer |
0.003 |
RAP2B, A XIN1, ARHGEF7, PTCH1, PTCH2, FOXO1, GAB1, RHOB, MAPK10, BID, MAP2K3, CDK2, CTNND1
|
|
|
Basal Cell Carcinoma Signaling |
0.005 |
GLI2, AXIN1, PTCH1, DVL3, PTCH2
|
|
|
Sonic Hedgehog Signaling |
0.010 |
GLI2, PTCH1, PTCH2
|
Group 3 cluster family D
|
(508 probes)
|
Phototransduction Pathway |
3.89E−10 |
PDE6G, GUCA1A, GNGT1, GNB5, PRKAR2A, PDE6H, GNB3, GNAT1, RHO, PDC, SAG, CNGB1, RCVRN
|
|
|
Protein Kinase A Signaling |
0.0087 |
RAF1, PDE6G, MYL6, PTP4A3, GNB5, PRKAR2A, MYL6B, PTPRF, PDE6H, GNB3, RHO, PPP1R10, TGFB1, TGFB3, CNGB1, TNNI1, CDC25A, MTMR3
|
|
|
Cyclins and Cell Cycle Regulation |
0.0138 |
RAF1, TGFB1, ABL1, TGFB3, HDAC5, CDC25A
|
|
|
Estrogen Receptor Signaling |
0.0141 |
CTBP1, RAF1, POLR2A, NCOR2, MED24, TRRAP, MED27, SMARCA4
|
Group 4 cluster family E
|
(343 probes)
|
Semaphorin Signaling in Neurons |
1.23E−05 |
RND2, CRMP1, DPYSL3, DPYSL4, DIRAS3, RAC1, FNBP1 |
|
|
Glioblastoma Multiforme Signaling |
7.41E−05 |
RND2, SRC, TSC1, DIRAS3, IGF1R, RAC1, PLCL2, CDKN1B, PLCH2, FNBP1 |
|
|
Axonal Guidance Signaling |
1.20E−04 |
NTF3, ITSN1, EPHB2, TUBB2A, RAC1, PLXNA2, PLCL2, GNAZ, PLCH2, NCK2, SRGAP3, PRKAR2B, TUBA1A, PTPN11, PPP3CB, GNAO1, BAIAP2 |
|
|
Gap Junction Signaling |
1.23E−04 |
DBN1, HTR2C, SRC, PRKAR2B, TUBA1A, PPP3CB, ADCY1, TUBB2A, PLCL2, PLCH2 |
|
|
Actin Nucleation by ARP-WASP Complex |
1.91E−04 |
RND2, NCK2, DIRAS3, BAIAP2, RAC1, FNBP1 |
|
|
Cardiac Hypertrophy Signaling |
0.001 |
RND2, PRKAR2B, PPP3CB, DIRAS3, GNAO1, ADCY1, IGF1R, PLCL2, GNAZ, PLCH2, FNBP1 |
|
|
Ephrin B Signaling |
0.001 |
NCK2, ITSN1, EPHB2, GNAO1, RAC1, GNAZ |
|
|
RhoGDI Signaling |
0.001 |
RND2, SRC, DIRAS3, GNAO1, RAC1, PIP4K2B, CDH18, GNAZ, FNBP1 |
|
|
Sphingosine-1-phosphate Signaling |
0.001 |
RND2, DIRAS3, ADCY1, RAC1, PLCL2, PLCH2, FNBP1 |
|
|
Regulation of Actin-based Motility by Rho |
0.001 |
RND2, DIRAS3, BAIAP2, RAC1, PIP4K2B, FNBP1 |
|
|
Clathrin-mediated Endocytosis Signaling |
0.002 |
SRC, ARRB1, PPP3CB, EPHB2, SH3GL3, RAC1, HIP1, FGF13, HIP1R |
|
|
Neuregulin Signaling |
0.002 |
SRC, PTPN11, ERBB4, CDKN1B, STAT5B, CDK5R1 |